Sanofi Troxerutin, 300 mg capsules 90 pcs

A semi-synthetic bioflavonoid (rutin derivative) of benzopyran class. Venotoninizing, angioprotective agent. It reduces capillary permeability and fragility, strengthens the vascular wall, improves microcirculation and has anti-edema effect.

It participates in redox processes, has antioxidant activity. It increases the density of the vascular wall, reduces the exudation of the liquid part of blood plasma and diapedesis of blood cells into the tissues, reduces inflammation in the vascular wall by limiting platelet adhesion to its surface.

The use of troxerutin is possible both in the initial and in the later stages of treatment of chronic venous insufficiency, it is possible to use as one of the components of complex treatment.

Troxerutin reduces swelling and heaviness in the legs, decreases the intensity of pain and cramps and improves tissue trophism.

Troxerutin relieves symptoms associated with hemorrhoids (pain, exudation, itching, bleeding).

Indications

– chronic venous insufficiency;

– trophic disorders in chronic venous insufficiency (dermatitis, trophic ulcers);

– varicose veins;

– superficial thrombophlebitis, periphlebitis;

– postthrombotic syndrome;

– Post-traumatic edema, bruises;

– hemorrhoids;

– diabetic angiopathy, retinopathy.

Active ingredient

Troxerutin

Composition

1 capsule contains:

the active ingredient:

troxerutin 300 mg;

excipients:

Macrogol 6000 12.00 mg,

Magnesium stearate 3.12 mg;

Capsule shell:

Case – titanium dioxide 2%, gelatin to 100%; cap – quinoline yellow dye 0.713%, iron oxide red dye 0.005%, titanium dioxide 2.000%, gelatin to 100%.